VERV Stock Sees Surge of Approximately 12.45% in Last Five Days

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Verve Therapeutics Inc shares valued at $6,343 were sold by Dorval Allison on Nov 29. At $11.45 per share, Dorval Allison sold 554 shares. The insider’s holdings dropped to 4,060 shares worth approximately $53916.799999999996 following the completion of this transaction.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

As published in their initiating research note from Canaccord Genuity on April 13, 2023, Verve Therapeutics Inc [VERV] has been a Buy and the price target has been revised to $29.

Analyzing VERV Stock Performance

During the last five days, there has been a surge of approximately 12.45%. Over the course of the year, Verve Therapeutics Inc shares have dropped approximately -4.73%. Shares of the company reached a 52-week high of $14.86 on 01/02/24 and a 52-week low of $10.31 on 02/05/24. A 50-day SMA is recorded $12.78, while a 200-day SMA reached $14.60. Nevertheless, trading volume fell to 0.92 million shares from 1.19 million shares the previous day.

Support And Resistance Levels for Verve Therapeutics Inc (VERV)

According to the 24-hour chart, there is a support level at 12.88, which, if violated, would cause prices to drop to 12.47. In the upper region, resistance lies at 13.62. The next price resistance is at 13.95. RSI (Relative Strength Index) is 56.95 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.93, which suggests the price will decrease in the coming days. Percent R is at 9.45%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.

Is Verve Therapeutics Inc subject to short interest?

Stocks of Verve Therapeutics Inc saw a sharp rise in short interest on Jan 31, 2024 jumping by 0.64 million shares to 12.37 million. Data from Yahoo Finance shows that the short interest on Dec 29, 2023 was 11.73 million shares. A jump of 5.17% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 12.75 of the overall float, the days-to-cover ratio (short ratio) jumped to 12.75.

Most Popular